RxDoctor Payments Data

Joelle Makon, MD

Physical Medicine & Rehabilitation · Mechanicsville, VANPI 1598021743

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 122 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 16.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $916 and has fallen 90.1% since, to $90 in 2024.

$1,842in general payments, 2019–2025

Across 122 payments — averaging $15.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$312
  • Teva Pharmaceuticals USA, Inc.$226
  • Arbor Pharmaceuticals, Inc.$224
  • Ipsen Biopharmaceuticals, Inc$206
  • Merz North America, Inc.$164
  • AbbVie$132
  • plus $578 from 15 others

What the payments were for

  • Food & beverage$1,842100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,842 in reported general payments places this provider in the 85th percentile of 231 physical medicine & rehabilitation providers in Virginia.

See all physical medicine & rehabilitation providers in Virginia

Medicare billing

Part B allowed, 2024
$204,218
Medicare patients
387
Services billed
2,322

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dutasteride13$661
Metolazone13$319
Donepezil Hcl14$316
Simvastatin16$283
Gabapentin26$232
Cephalexin14$227
Potassium Chloride11$127
Tamsulosin Hcl12$95
Oxycodone Hcl28$94
Pantoprazole Sodium13$86
Folic Acid12$62
Metoprolol Tartrate13$42
Tramadol Hcl18$21
Amlodipine Besylate12$20
Furosemide11$20

Paid to pharmacies, not to this prescriber.

Other physical medicine & rehabilitation in Mechanicsville

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →